Responsiveness and meaningful thresholds of PROMIS pain interference, fatigue, and physical function forms in adults with idiopathic inflammatory myopathies: Report from the OMERACT Myositis Working Group-Reference-Cited by-同舟云学术

Responsiveness and meaningful thresholds of PROMIS pain interference, fatigue, and physical function forms in adults with idiopathic inflammatory myopathies: Report from the OMERACT Myositis Working Group

Published:2024-02 Issue: Volume:64 Page:152339
ISSN:0049-0172
Container-title:Seminars in Arthritis and Rheumatism
language:en
Short-container-title:Seminars in Arthritis and Rheumatism

Author:

Saygin D^ORCID,DiRenzo D,Raaphorst J,de Groot I,Bingham CO,Lundberg IE,Regardt M,Sarver C,de Visser M,Maxwell LJ,Beaton D,Kim JY,Needham M,Alexanderson H,Christopher-Stine L,Mecoli CA,Park JK

Publisher

Elsevier BV

Subject

Anesthesiology and Pain Medicine,Rheumatology

Reference34 articles.

1. Idiopathic inflammatory myositis is associated with a high incidence of hypertension and diabetes mellitus;Limaye;Int J Rheum Dis,2010

2. Idiopathic inflammatory myopathies - a guide to subtypes, diagnostic approach and treatment;Oldroyd;Clin Med,2017

3. New myositis classification criteria-what we have learned since Bohan and Peter;Leclair;Curr Rheumatol Rep,2018

4. Idiopathic inflammatory myopathies;Lundberg;Nat Rev Dis Primers,2021

5. OMERACT Myositis Working Group. 2023. https://omeract.org/working-groups/myositis/. In.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Construct validity of PROMIS pain interference, fatigue, and physical function as patient-reported outcomes in adults with idiopathic inflammatory myopathies: An international study from the OMERACT myositis working group;Seminars in Arthritis and Rheumatism;2024-10

2. Fostering connections at OMERACT 2023: A collaborative approach to Core Outcome Set development;Seminars in Arthritis and Rheumatism;2024-08

3. The impact of pain on daily activities in patients with idiopathic inflammatory myopathies: Report from the OMERACT myositis working group;Seminars in Arthritis and Rheumatism;2024-08